Infinity cuts drug discovery operations

Thursday, June 16, 2016 - 20:30 in Health & Medicine

Decision comes after a failed clinical trial for the PI3K inhibitor duvelisib

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net